N/A N=39 Single-blind Diagnostic

Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time

Myocardial Infarction · Myocardial Ischemia

Bottom Line

View on ClinicalTrials.gov: NCT01877941 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2015

Primary outcome: Primary: esCCO (Estimated Continuous Cardiac Output) Monitor — 5.6 liters/minute

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Pulmonary Artery Catheter (PAC) (Device); Endotracheal Cardiac Output Monitor (ECOM) (Device); Estimated Continuous Cardiac Output (esCCO) (Device)
Age: Adult, Older Adult · 19+ yrs
Sex: All
Sponsor: University of California, San Francisco
Primary completion: Nov 2013

Outcome Measures

Outcome	Result	p-value
PRIMARY esCCO (Estimated Continuous Cardiac Output) Monitor	5.6	—
PRIMARY PAC (Pulmonary Artery Catheter).	4.95	—
PRIMARY Cardiac Output as Measured by ECOM	—	—

Summary

The specific aim of this study is to assess whether a device approved by the FDA to measure pulse oximetry can accurately estimate cardiac output.

Eligibility Criteria

Inclusion Criteria

Patients undergoing surgery where cardiac output will be measured with PAC and ECOM.

Exclusion Criteria

Failure to obtain consent.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01877941). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.